Literature DB >> 16261158

Multiple alternate p21 transcripts are regulated by p53 in human cells.

S K Radhakrishnan1, J Gierut, A L Gartel.   

Abstract

The p53 tumor-suppressor is a transcription factor that is stabilized in response to cellular stress leading to growth arrest or apoptosis. p21(WAF1/CIP1) is a major transcriptional target of p53 and it plays a critical role in p53-dependent cell cycle arrest. In this study, we identified multiple alternate human p21 transcripts that have their transcriptional start sites in the direct proximity of the distal p53 response element. These transcripts are upregulated as a result of DNA damage-induced p53 activation. Furthermore, the basal expression of these alternate transcripts is strongly regulated by p53 and they are undetectable in p53-knocked down cells. This is in contrast to classical p21 transcripts, which have reduced, albeit detectable expression levels in the absence of p53. The existence of the alternate transcripts underscores the complexity of the human p21 genomic locus and opens up new avenues for further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16261158     DOI: 10.1038/sj.onc.1209195

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Proteasome inhibitors induce p53-independent apoptosis in human cancer cells.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  TATA-binding protein (TBP)-like protein is required for p53-dependent transcriptional activation of upstream promoter of p21Waf1/Cip1 gene.

Authors:  Hidefumi Suzuki; Ryo Ito; Kaori Ikeda; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2012-04-16       Impact factor: 5.157

3.  Interaction of mutant hepatitis B X protein with p53 tumor suppressor protein affects both transcription and cell survival.

Authors:  Shoba Iyer; John D Groopman
Journal:  Mol Carcinog       Date:  2011-03-22       Impact factor: 4.784

4.  Proteasome inhibitors suppress the protein expression of mutant p53.

Authors:  Marianna Halasi; Bulbul Pandit; Andrei L Gartel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Authors:  Jin Zhang; Xiangling Chen; Michael S Kent; Carlos O Rodriguez; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

6.  New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.

Authors:  Bulbul Pandit; Andrei L Gartel
Journal:  Prostate       Date:  2010-06-01       Impact factor: 4.104

7.  EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis.

Authors:  Ting-Yun Liu; Shang-Ju Wu; Mi-Hsin Huang; Fei-Yun Lo; Mong-Hsun Tsai; Ching-Hwa Tsai; Su-Ming Hsu; Chung-Wu Lin
Journal:  Mol Cancer       Date:  2010-02-09       Impact factor: 27.401

8.  p21(Cip1) protects against oxidative stress by suppressing ER-dependent activation of mitochondrial death pathways.

Authors:  Peter F Vitiello; Yu-Chieh M Wu; Rhonda J Staversky; Michael A O'Reilly
Journal:  Free Radic Biol Med       Date:  2008-10-07       Impact factor: 7.376

9.  TGFβ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1.

Authors:  Javier Palazuelos; Michael Klingener; Adan Aguirre
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

10.  Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites.

Authors:  Matteo Rossi; Oleg N Demidov; Carl W Anderson; Ettore Appella; Sharlyn J Mazur
Journal:  Nucleic Acids Res       Date:  2008-11-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.